Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma

By Higashijima T.   Kataoka A.   Nishida T.   Yakushiji M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 169-173

Elsevier

Access to resources Recommend Favorite

Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist

By Yu K.-J.   Lai C.-R.   Sheu M.-H.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 96, Iss. 2, 2001-06 ,pp. : 223-225

Elsevier

Access to resources Recommend Favorite

Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment

By Ito F.   Kawamura N.   Ichimura T.   Tsujimura A.   Ishiko O.   Ogita S.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 125-130

Elsevier

Access to resources Recommend Favorite

Effects of a Gonadotropin-Releasing Hormone agonist and Follicle Stimulating Hormone on the incidence of apoptosis in human luteinized granulosa cells

By Sifer C.   Blanc-Layrac G.   Bringuier A.-F.   Porcher R.   Madelenat P.   Feldmann G.   Benifla J.-L.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 110, Iss. 1, 2003-09 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Prediction of the change in bone mineral density induced by gonadotropin-releasing hormone agonist treatment for endometriosis

By Matsuo H.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 149-153

Elsevier

Access to resources Recommend Favorite